Global Congress 2022 Americas
Attend Expanded Access Programmes
Expanded access or compassionate use is the use of an unauthorized drug or medical device under special forms of investigational new drug applications (IND) or IDE application for devices, outside of a clinical trial, by the patient with an immediately life-threatening illness or severely debilitating disease or condition who do not meet the enrollment criteria for the clinical trial in progress. These programs go under various names, including early access, special access, or managed access program, compassionate access, named-patient
access, temporary authorization for use, cohort access, and pre-approval access.
The two-day Congress will provide an interactive, cutting edge and comprehensive discussion and networking format led by key expert speakers with intimate knowledge in the industry. Gain practical strategies and best practices on challenges, innovations, technologies and concepts in obtaining the much-needed access to these therapies for life-changing treatment.
The objective of this 2-day interactive congress is to provide the audience with much-needed skills, best practices, innovations, technologies and concepts in obtaining the much-needed access to these therapies for life-changing treatment, led by key expert stakeholders with intimate knowledge in the industry.
We look forward to welcoming you at the Congress!
Attend 3rd Expanded Access Programmes 2022 Americas
Expanded Access Programmes Americas
Special Group Discounts: Sign up with your team for even more savings!!!
Patient Groups: Free (Register in advance to guarantee your place)